Login / Signup

Preoperative docetaxel, cisplatin, and fluorouracil treatment with pegfilgrastim on day 7 for patients with esophageal cancer: A phase II study.

Osamu MaedaMasahide FukayaMasahiko KoikeKazushi MiyataMitsuro KandaKazuki NishidaMasahiko AndoYasuhiro KoderaYuichi Ando
Published in: Asia-Pacific journal of clinical oncology (2022)
Since the histopathological responses were as expected, DCF with prophylactic pegfilgrastim is considered to be effective as preoperative chemotherapy. However, the prophylactic use of pegfilgrastim on day 7 was insufficient to prevent FN.
Keyphrases
  • phase ii study
  • locally advanced
  • chemotherapy induced
  • patients undergoing
  • rectal cancer
  • open label
  • squamous cell carcinoma
  • radiation therapy
  • clinical trial
  • placebo controlled